Shen Yuan, Gong Zhiguo, Zhang Shuangyi, Cao Jinshan, Mao Wei, Fu Yunhe, Su Niri, Ding Yulin, Zhao Jiamin, Gu Baichen, Feng Shuang, Liu Bo
Laboratory of Veterinary Clinical Pharmacology, College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot, China.
Key Laboratory of Clinical Diagnosis and Treatment Techniques for Animal Disease, Ministry of Agriculture, Inner Mongolia Agricultural University, Hohhot, China.
Microbiol Spectr. 2023 Mar 14;11(2):e0354122. doi: 10.1128/spectrum.03541-22.
Escherichia coli (E. coli), a Gram-negative bacterium, is an important pathogen that causes several mammalian diseases. The outer membrane components of E. coli, namely, lipopolysaccharide (LPS) and bacterial lipoprotein, can induce the host innate immune response through pattern recognition receptors (PRRs). However, the detailed roles of the E. coli Braun lipoprotein (BLP) in the regulation of host inflammatory response to E. coli infection remain unclear. In this study, we sought to determine the effects of BLP on E. coli-induced host inflammatory response and lethality using mouse models. Experiments using the E. coli DH5α strain (BLP-positive), E. coli JE5505 strain (BLP-negative), and E. coli JE5505 strain combined with BLP indicated that the presence of BLP could alleviate mortality and organ (liver and lung) damage and decrease proinflammatory cytokine (tumor necrosis factor alpha [TNF-α] and interleukin-1β [IL-1β]) and chemokine (regulated on activation normal T-cell expressed and secreted [RANTES]) production in mouse serum and organs. Conversely, E. coli JE5505, E. coli DH5α strain, and E. coli JE5505 combined with BLP treatment induce enhanced anti-inflammatory cytokine (interleukin 10 [IL-10]) production in mouse serum and organs. In addition, BLP could regulate the secretion of proinflammatory cytokines (TNF-α and IL-1β), chemokines (RANTES), and anti-inflammatory factors (IL-10) through mitogen-activated protein kinase (MAPK) and nuclear factor-kappaB (NF-κB) signaling pathways in macrophages. Altogether, our results demonstrate that the bacterial component BLP plays crucial and protective roles in E. coli-infected mice, which may influence the outcome of inflammation in host response to E. coli infection. In this study, we investigated the roles of bacterial outer membrane component BLP in regulating inflammatory responses and lethality in mice that were induced by a ubiquitous and serious pathogen, Escherichia coli. BLP could alleviate the mortality of mice and organ damage, as well as decrease proinflammatory cytokines and chemokine production and enhance anti-inflammatory cytokine production in mouse serum and organs. Overall, our results demonstrate that the bacterial component BLP plays crucial and protective roles in E. coli-infected mice through regulating the production of an inflammatory mediator, which may influence the outcome of inflammation in host response to E. coli infection. Our findings provide new information about the basic biology involved in immune responses to E. coli and host-bacterial interactions, which have the potential to translate into novel approaches for the diagnosis and treatment of E. coli-related medical conditions, such as bacteremia and sepsis.
大肠杆菌(E. coli)是一种革兰氏阴性菌,是引起多种哺乳动物疾病的重要病原体。大肠杆菌的外膜成分,即脂多糖(LPS)和细菌脂蛋白,可通过模式识别受体(PRR)诱导宿主先天免疫反应。然而,大肠杆菌布劳恩脂蛋白(BLP)在调节宿主对大肠杆菌感染的炎症反应中的具体作用仍不清楚。在本研究中,我们试图使用小鼠模型确定BLP对大肠杆菌诱导的宿主炎症反应和致死率的影响。使用大肠杆菌DH5α菌株(BLP阳性)、大肠杆菌JE5505菌株(BLP阴性)以及大肠杆菌JE5505菌株与BLP组合进行的实验表明,BLP的存在可减轻死亡率和器官(肝脏和肺)损伤,并降低小鼠血清和器官中促炎细胞因子(肿瘤坏死因子α [TNF-α]和白细胞介素-1β [IL-1β])以及趋化因子(活化正常T细胞表达和分泌调节因子[RANTES])的产生。相反,大肠杆菌JE5505、大肠杆菌DH5α菌株以及大肠杆菌JE5505与BLP组合处理可诱导小鼠血清和器官中抗炎细胞因子(白细胞介素10 [IL-10])产生增加。此外,BLP可通过巨噬细胞中的丝裂原活化蛋白激酶(MAPK)和核因子κB(NF-κB)信号通路调节促炎细胞因子(TNF-α和IL-1β)、趋化因子(RANTES)以及抗炎因子(IL-10)的分泌。总之,我们的结果表明,细菌成分BLP在大肠杆菌感染的小鼠中发挥关键的保护作用,这可能会影响宿主对大肠杆菌感染的炎症反应结果。在本研究中,我们研究了细菌外膜成分BLP在调节由普遍存在且严重的病原体大肠杆菌诱导的小鼠炎症反应和致死率中的作用。BLP可减轻小鼠的死亡率和器官损伤,以及降低小鼠血清和器官中促炎细胞因子和趋化因子的产生,并增加抗炎细胞因子的产生。总体而言,我们的结果表明,细菌成分BLP通过调节炎症介质的产生在大肠杆菌感染的小鼠中发挥关键的保护作用,这可能会影响宿主对大肠杆菌感染的炎症反应结果。我们的发现为大肠杆菌免疫反应和宿主 - 细菌相互作用所涉及的基础生物学提供了新信息,这些信息有可能转化为诊断和治疗与大肠杆菌相关的医学病症(如菌血症和败血症)的新方法。